Anthropic Approved to List on Nasdaq: What Happens Next

By: WEEX|

Anthropic reported on November 17, 2026, that its Class A common stock has been approved for listing on the Nasdaq Global Select Market under the ticker ANT, and the next steps are the IPO pricing, reported for Wednesday, November 18, and the first trade on Nasdaq, reported for Thursday, November 19. 

The Anthropic Nasdaq listing approval does not set the final IPO price or start trading by itself. Anthropic’s proposed price range of $70 to $78 per share was reported as unchanged, but the final price is only known after pricing.

What Did Anthropic’s Nasdaq Approval Actually Say?

The approval came from Anthropic itself. Newsquawk reported on November 17, 2026, that Anthropic said its Class A common stock “has been approved for listing” on the Nasdaq Global Select Market under the ticker “ANT,” according to a filing. Investing.com carried the same statement under the headline “Anthropic: have been approved to list our Class A common stock on NASDAQ Global Select market under symbol ‘ANT’.” PANews, in a report republished on TradingView, described the same news as Anthropic being “approved to list.”

The reports are short, and what they leave out matters. None of the pages I could read says which filing carries the statement, and none says whether the approval is a final listing approval, a conditional one or part of a wider step. The report that carries the wording does not give a price, a share count, a valuation or a timetable from the filing itself. Anything beyond the approval and the ticker therefore comes from other sources and should be treated as reported, not as part of this announcement.

The ticker and the exchange tier are the two firm details. ANT is the symbol, and the Nasdaq Global Select Market is the tier named in the reports. Both match what earlier coverage of Anthropic’s IPO filing said, so the approval confirms those details rather than changing them. The price range, share count and valuation come from the S-1/A and are not part of this approval, so they are not repeated here.

Anthropic Approved to List on Nasdaq: What Happens Next

Does Approval Mean ANT Is Already Trading?

No. An approval to list means the exchange has agreed to list the shares under the ticker. It does not mean the shares have been priced or that anyone can buy them yet. The reports that carry the approval describe the IPO as still ahead, with trading expected after pricing, so ANT should not be treated as a live stock on November 17.

The timing is reported but not confirmed by the approval. Media reports put the IPO pricing on Wednesday, November 18, and the first day of trading on Thursday, November 19, on Nasdaq. Earlier in this series, those dates were described as reported by media and not as part of the S-1/A. The approval news does not add a date, so readers should expect the schedule to be confirmed only when Anthropic and its underwriters announce the final price and the start of trading.

The approval also came with another reported detail: Anthropic confirmed no change to its proposed price range of $70 to $78 per share, according to a November 17 report on the FVBB news aggregator that credits the Economic Times. That report is secondary and I could not trace it to a filing, so it is best read as “reported unchanged” until the pricing announcement. A range that stays the same does not tell readers where within, or outside, the range the final price will land.

What Gets Decided Before the First Trade?

The main decision still to come is the final IPO price. In a typical IPO, the price range in the filing is a proposal, and the final price is set at pricing, after the company and its underwriters have collected orders. For Anthropic, the proposed range is $70 to $78, and the final price could be set inside that range or outside it. This is the standard way the process works, not an Anthropic-specific fact, so readers should expect the official figure only in the pricing announcement.

The number of shares and the allocation are also fixed at pricing. Earlier coverage based on the S-1/A described the size of the offering, the retail share and the over-allotment option, and those details can still move until the final pricing documents are filed. A figure from the S-1/A should therefore be compared with the final announcement before it is cited.

A third open item is the opening trade itself. Even after pricing, the first trade on Nasdaq happens when the market opens on the first trading day, and the price at which ANT first trades can differ from the IPO price. This article does not forecast where it will open. What can be said is that the IPO price and the first trading price are two separate numbers, and the first one is set at pricing while the second is set by the market on day one.

-- Price

--
--
--

What Happens After the First Trade?

Several arrangements described in the S-1/A start only after trading begins. Morgan Stanley is named as the stabilizing agent, and the filing describes an over-allotment option of 123.75 million shares that the underwriters can use in connection with stabilization. Stabilization means the underwriters may buy shares in the market to support the price for a limited period after the IPO, and the filing describes it as something that may happen, not something that is promised.

Lock-up restrictions are the other post-trade milestone. The S-1/A describes lock-ups of 180 and 365 days for different holders, and it says that a portion of shares, about 3.6 billion according to earlier coverage, may be sold earlier under specific conditions. These periods start counting from the offering and are not triggered by the Nasdaq approval. The approval therefore does not change when insiders can sell. What it changes is that the clock can start once the IPO is priced and shares begin trading.

Readers who want the full list of terms should read the filing and its amendments, because later amendments can change them. Anthropic’s governance structure, including the voting classes and the “controlled company” status, is also described in the S-1/A and does not change with the Nasdaq approval. For a first-time reader, the practical point is that listing approval is one step in a sequence: approval, pricing, first trade, then the stabilization and lock-up periods described in the filing.

What Happens After the First Trade ANT

How Reliable Are the Reports, and How Can You Check Them?

The approval news reached readers through a chain of short reports, and the chain is worth reading before the figures are cited. Newsquawk reported on November 17, 2026, at 11:50 UTC that Anthropic said its Class A common stock was approved for listing, and that the statement came from a filing. Investing.com carried the same statement under a headline that quotes Anthropic’s wording. PANews reported it too, and TradingView republished the PANews report. These pages repeat one announcement, not four separate confirmations, so the number of headlines does not make the claim stronger.

The price detail has a longer chain. The statement that Anthropic’s proposed range stays at $70 to $78 per share appeared on the FVBB news aggregator on November 17, 2026, with the Economic Times credited as the original source, and I could not trace it to a filing. The Newsquawk report, which does cite a filing for the approval, gives no price range at all. Readers should therefore treat the approval as reported by several outlets from Anthropic’s own statement, and the unchanged price range as a single secondary report until the pricing announcement shows the final terms.

The most reliable check is Anthropic’s own filing record on the SEC’s EDGAR database, where the S-1 and its amendments are public. A filing can be read for the exact wording of the Nasdaq listing statement, the date it was filed and which version of the terms it belongs to, which the news reports do not say. After pricing, the final prospectus is normally filed with the SEC, and that document, not a news summary, is the version to cite for the final price and share count. Readers who see a number in a headline should compare it with the filing, and where the two differ, the filing is the one that counts.

What Should Readers Watch Over the Next Few Days?

The first thing to watch is the pricing announcement. It should show the final IPO price, the number of shares sold and whether the range or the share count changed. Readers who saw the $70 to $78 range should check the final figures against it, because the final terms are the ones that apply. Until that announcement, any “expected” price or opening level is a forecast, not a fact.

The second thing is the filing record. Anthropic’s statement about the Nasdaq approval is reported to come from a filing, and later amendments or prospectus filings may change terms. Reading the SEC’s EDGAR record for Anthropic is the way to check which version of a number is current, because news reports often cite earlier drafts. A report that says “approved” without naming the filing, as these reports do, is a reason to open the filing itself.

The third is the market context around the listing. Reports tie the timing of the IPO to a busy week for tech stocks, and the first day of trading can be volatile for any new listing. This article does not predict prices or give investment advice. Readers who plan to trade should confirm the final terms, the broker’s access to ANT on the first day and their own risk limits before placing any order.

Conclusion

Anthropic reported that its Class A stock is approved for listing on the Nasdaq Global Select Market under the ticker ANT. The approval confirms the exchange and the ticker, but it does not set the final price, start trading or change the lock-up terms. Pricing and the first trade are reported for November 18 and 19, and the proposed range was reported as unchanged. Check the final pricing announcement and the filing record before relying on any number.

FAQ

1. Has Anthropic been approved to list on Nasdaq?
Anthropic said on November 17, 2026, that its Class A common stock has been approved for listing on the Nasdaq Global Select Market under the ticker ANT, according to a filing.

2. Is ANT trading yet?
No. The approval is not the same as pricing or trading. Media reports put the pricing on Wednesday, November 18, and the first day of trading on Thursday, November 19, but those dates are reported, not part of the approval.

3. Did Anthropic change its IPO price range?
A November 17 report said Anthropic confirmed no change to its proposed range of $70 to $78 per share. The report is secondary, so the final price should be checked in the pricing announcement.

4. What is decided at pricing?
The final IPO price, the number of shares sold and the allocation are set at pricing. The S-1/A figures are proposals until the final documents are filed.

5. What happens after ANT starts trading?
The S-1/A describes possible price stabilization by Morgan Stanley, an over-allotment option of 123.75 million shares and lock-ups of 180 and 365 days for different holders.

This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.

You may also like

iconiconiconiconiconiconiconiconicon
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Program:support@weex.com